Edwards Lifesciences Corporation Common Stock vs Gerdau S.A. Common Stock — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.25 (market cap $49.44B), while Gerdau S.A. Common Stock trades at $4.94 (market cap $9.38B). The key difference: Edwards Lifesciences Corporation Common Stock is far larger — about 5.3× Gerdau S.A. Common Stock's market cap, and Gerdau S.A. Common Stock pays a 3.59% dividend while Edwards Lifesciences Corporation Common Stock pays none. Which is the better fit depends on your goals.
| EW | GGB | |
|---|---|---|
Market Cap | $49.44B | $9.38B |
Volume | 3,508,027 | 13,301,134 |
Sector | Health | Basic Materials |
52-Week High | $95.18 | $5.17 |
52-Week Low | $72.65 | $3.15 |
Enterprise Value | $45.90B | $11.33B |
Typical Hold Time | — | 0 Days |
Dividend Yield | — | 3.59% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →Gerdau is a steel producer with operations across the Americas. It makes long steel, specialty steel, and other products for construction and industrial markets.
Read more on GGB →